• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[莫西沙星与巨噬细胞清道夫受体配体缀合物的抗结核活性研究]

[Study of antituberculous activity of moxifloxacin conjugate with macrophage scavenger-receptor ligand].

作者信息

Azaev M Sh, Agafonov A P, Bodnev S A, Blinov V M

出版信息

Antibiot Khimioter. 2006;51(11-12):7-10.

PMID:18318141
Abstract

Mycobacterium tuberculosis is an intracellular pathogen that persists in macrophages of the human host. An approach to improving the treatment of tuberculosis is target delivery of antibiotics to macrophages using ligands to macrophage receptors. The antituberculous activity of the conjugate of the antituberculous antibiotic moxifloxacin with carboxymethylglucan was studied in vitro using the J774 macrophage cell line and peritoneal macrophages. The antituberculous activity of the conjugate was higher than of the free moxifloxacin. The target antibiotic delivery to macrophage cells in tuberculosis infection was shown perspective.

摘要

结核分枝杆菌是一种胞内病原体,可在人类宿主的巨噬细胞中持续存在。改善结核病治疗的一种方法是使用巨噬细胞受体的配体将抗生素靶向递送至巨噬细胞。使用J774巨噬细胞系和腹膜巨噬细胞在体外研究了抗结核抗生素莫西沙星与羧甲基葡聚糖缀合物的抗结核活性。该缀合物的抗结核活性高于游离莫西沙星。结果表明,在结核病感染中向巨噬细胞靶向递送抗生素具有前景。

相似文献

1
[Study of antituberculous activity of moxifloxacin conjugate with macrophage scavenger-receptor ligand].[莫西沙星与巨噬细胞清道夫受体配体缀合物的抗结核活性研究]
Antibiot Khimioter. 2006;51(11-12):7-10.
2
Novel conjugate of moxifloxacin and carboxymethylated glucan with enhanced activity against Mycobacterium tuberculosis.莫西沙星与羧甲基化葡聚糖的新型缀合物,对结核分枝杆菌具有增强活性。
Antimicrob Agents Chemother. 2006 Jun;50(6):1982-8. doi: 10.1128/AAC.00362-05.
3
Should moxifloxacin be substituted for isoniazid as a first-line antituberculosis drug?莫西沙星是否应替代异烟肼作为一线抗结核药物?
Am J Respir Crit Care Med. 2009 Oct 1;180(7):686; author reply 686-7. doi: 10.1164/ajrccm.180.7.686a.
4
Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.莫西沙星治疗肺结核的早期杀菌活性:一项前瞻性随机研究。
Antimicrob Agents Chemother. 2004 Mar;48(3):780-2. doi: 10.1128/AAC.48.3.780-782.2004.
5
Effect of coadministration of moxifloxacin and rifampin on Mycobacterium tuberculosis in a murine aerosol infection model.莫西沙星与利福平联合给药对小鼠雾化感染模型中结核分枝杆菌的影响。
Antimicrob Agents Chemother. 2012 Jun;56(6):3054-7. doi: 10.1128/AAC.06383-11. Epub 2012 Apr 2.
6
Moxifloxacin population pharmacokinetics in patients with pulmonary tuberculosis and the effect of intermittent high-dose rifapentine.莫西沙星治疗肺结核患者的群体药代动力学研究及间歇高剂量利福喷汀的影响。
Antimicrob Agents Chemother. 2012 Aug;56(8):4471-3. doi: 10.1128/AAC.00404-12. Epub 2012 May 14.
7
Moxifloxacin versus ethambutol in initial tuberculosis treatment.莫西沙星与乙胺丁醇用于初治肺结核的治疗比较
Lancet. 2009 Jun 27;373(9682):2197-8; author reply 2198-9. doi: 10.1016/S0140-6736(09)61188-0.
8
Moxifloxacin for tuberculosis.莫西沙星用于治疗结核病。
Lancet Infect Dis. 2012 Mar;12(3):176-7; author reply 177-8. doi: 10.1016/S1473-3099(11)70351-6.
9
Moxifloxacin for tuberculosis.莫西沙星用于治疗结核病。
Lancet Infect Dis. 2012 Mar;12(3):176; author reply 177-8. doi: 10.1016/S1473-3099(11)70350-4.
10
Moxifloxacin versus ethambutol in initial tuberculosis treatment.莫西沙星与乙胺丁醇用于初治结核病的治疗比较
Lancet. 2009 Jun 27;373(9682):2198; author reply 2198-9. doi: 10.1016/S0140-6736(09)61189-2.